Capillary Hemangioma
Return to Library
Researchers from Hadassah University publish new studies and findings in the area of biopsy
2009 JUL 20 - (NewsRx.com) -- According to recent research from Jerusalem, Israel, "Magnetic resonance imaging of the breast has emerged as a valuable imaging tool in addition to conventional imaging modalities. It has high sensitivity for malignant lesions and can detect mammographically, sonographically and clinically occult cancers. ''MR only'' lesions are best biopsied under MR guidance; however, this may be a challenging task." "To evaluate our initial clinical experience with MR-guided core needle breast biopsy and MR-guided needle localization. We retrospectively evaluated 81 women with 97 lesions, who were scheduled for guided core needle biopsy or MR-guided needle localization followed by surgery. Lesions were categorized as malignant, high risk, or benign according to the BI-RADS MR classification system. MR findings were compared with final histopathology or with follow-up imaging findings. Fifteen (16%) lesions were malignant (9 invasive ductal carcinoma, 2 invasive lobular carcinoma, 4 ductal carcinoma in situ); 7 (7%) lesions were high risk (4 atypical ductal hyperplasia, 3 radial scars); 75 (77%) lesions were benign, mainly fibrocystic changes. Other benign findings were sclerosing adenosis, pseudoangiomatous stromal hyperplasia, fat necrosis, intraductal papilloma, fibroadenoma, capillary hemangioma, and florid ductal hyperplasia. No major complications were encountered," wrote R. Eliahou and colleagues, Hadassah University. The researchers concluded: "MR-guided interventional procedures of the breast are accurate, safe and feasible methods for sampling breast lesions detected only by MR and have become a significant tool in the management of certain patients. IMAJ 2009;11:275-279'." Eliahou and colleagues published their study in Israel Medical Association Journal (Magnetic Resonance-Guided Interventional Procedures of the Breast: Initial Experience. Israel Medical Association Journal, 2009;11(5):275-279). For additional information, contact R. Eliahou, Hadassah University, Dept. of Radiol, POB 12000, IL-91120 Jerusalem, Israel. Publisher contact information for the Israel Medical Association Journal is: Israel Medical Association Journal, 2 Twin Towers, 11TH FL, 35 Jabotinsky St., PO Box 3604, Ramat GaN 52136, Israel. Keywords: Israel, Jerusalem, Biopsy, Breast Cancer, Breast Carcinoma, Clinically Occult Cancer, Clinically Occult Carcinoma, Diagnosis, Diagnostics, Magnetic Resonance, Oncology, Surgery, Women's Health, Hadassah University. This article was prepared by Clinical Oncology Week editors from staff and other reports. Copyright 2009, Clinical Oncology Week via NewsRx.com.
|
